Regulation Decimation Act

The Regulation Decimation Act (HR710) requires federal agencies to repeal ten existing rules for every new rule issued that imposes a cost or responsibility on a nongovernmental person or a state or local government. For major rules, the cost of the new rule must also be less than or equal to the cost of the rules repealed. This mechanism directly reduces the regulatory burden on businesses, leading to immediate cost savings and improved operational efficiency. This is a direct reduction in overhead for companies operating in highly regulated environments. There is no direct funding or money trail associated with this bill; instead, it creates value through regulatory relief. The financial benefit comes from reduced compliance costs, fewer reporting requirements, and increased flexibility in operations. This translates directly to higher net income for companies that previously allocated significant resources to navigate complex regulatory landscapes. The Office of Information and Regulatory Affairs of the Office of Management and Budget will certify the cost savings for major rules, ensuring the intended financial benefit is realized. Historically, efforts to reduce regulatory burdens have consistently led to increased corporate profitability and investment. For example, the Trump administration's executive orders in 2017, which aimed for a 'two-for-one' rule reduction, correlated with a period of sustained corporate profit growth and increased capital expenditures. While a direct market-wide impact from those specific orders is hard to isolate due to other concurrent policy changes, individual companies in sectors like energy and manufacturing reported reduced compliance costs. When the Congressional Review Act was used to repeal various Obama-era regulations in 2017, companies like $XOM and $CVX saw modest gains in the weeks following, as investors anticipated reduced environmental compliance costs. Specific winners include companies in heavily regulated sectors. In Healthcare, $JNJ and $PFE will see reduced compliance costs for drug development and manufacturing. In Energy, $XOM and $CVX will benefit from streamlined environmental and operational regulations. Financial institutions like $BAC and $WFC will experience relief from complex banking regulations. Manufacturing giants such as $GE and $MMM will gain from fewer industrial and environmental compliance hurdles. Transportation companies like $UNP and $CSX will see reduced operational and safety regulation costs. The bill's sponsor, Rep. Taylor, a Republican, indicates a strong push from the party generally favoring deregulation, giving this bill moderate momentum despite being early in the legislative process. This bill has been referred to the Committee on Oversight and Government Reform and the Committee on the Judiciary. The next step involves committee hearings and potential markups. If it passes committee, it will proceed to a House floor vote. The earliest significant market reaction would occur upon successful passage in the House, with further impact if it advances through the Senate. The requirement for agencies to submit a report within 90 days of enactment, identifying costly or outdated rules, sets an immediate timeline for initial regulatory review.